Reproductive Toxicity Risk Tool Should Be Revised, Schering-Plough Says
Executive Summary
Schering-Plough is recommending that FDA's proposed integrative assessment tool for evaluating reproductive toxicity be revised to reduce the number of categories and remove the number scale for assigning patient risk